dydrogesterone has been researched along with fibrinogen in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbosa, J; Doe, RP; Seal, US | 2 |
| Emeis, JJ; Kenemans, P; Mijatovic, V; Schalkwijk, CG; Stehouwer, CD; van Baal, WM; van der Mooren, MJ; Vischer, UM | 1 |
| de Kraker, AT; Kenemans, P; Kroeks, MV; Smolders, RG; van der Mooren, MJ | 1 |
| Borowiecka, M; Nowak, P; Polac, I; Ponczek, MB; Radwan, P; Wachowicz, B | 1 |
3 trial(s) available for dydrogesterone and fibrinogen
| Article | Year |
|---|---|
Effects of steroids on plasma proteins--progestational agents.
Topics: Adolescent; Adult; Alpha-Globulins; Androgen Antagonists; Animals; Blood Proteins; Chlormadinone Acetate; Clinical Trials as Topic; Contraceptives, Oral; Dydrogesterone; Ethisterone; Female; Fibrinogen; Glucuronidase; Haplorhini; Haptoglobins; Humans; Hydrocortisone; Male; Medroxyprogesterone; Norethindrone; Plasminogen; Pregnanes; Progesterone; Thromboembolism; Thyroxine-Binding Proteins; Transcortin; Trypsin Inhibitors | 1971 |
Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women.
Topics: Dydrogesterone; E-Selectin; Endothelin-1; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Humans; Inflammation; Middle Aged; Postmenopause; Prospective Studies; Solubility; Thrombomodulin; von Willebrand Factor | 1999 |
Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: a randomised controlled trial.
Topics: Adult; alpha-2-Antiplasmin; Antigens; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Drug Combinations; Dydrogesterone; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Fibrinolysin; Homocysteine; Humans; Insulin-Like Growth Factor I; Medroxyprogesterone Acetate; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Risk Factors; Time Factors; Tissue Plasminogen Activator | 2009 |
2 other study(ies) available for dydrogesterone and fibrinogen
| Article | Year |
|---|---|
Anti-estrogens and plasma proteins. II. Contraceptive drugs and gestagens.
Topics: Adolescent; Adult; Animals; Blood Proteins; Chlormadinone Acetate; Contraceptives, Oral; Cyproterone; Dydrogesterone; Ethinyl Estradiol; Female; Fibrinogen; Haplorhini; Haptoglobins; Humans; Hydrocortisone; Male; Norethindrone; Norgestrel; Plasminogen; Thyroxine; Thyroxine-Binding Proteins; Transferrin | 1973 |
Changes in hemostatic parameters after oral hormone therapy in postmenopausal women.
Topics: Case-Control Studies; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Longitudinal Studies; Middle Aged; Partial Thromboplastin Time; Platelet Count; Postmenopause; Prothrombin; Prothrombin Time; Risk Factors; Thrombophilia | 2010 |